Evidence map›Paper›PMID 37138555›Full record

ArticleTransplantation direct2023

Tissue and Cell Donation: Recommendations From an International Consensus Forum.

Jacinto Sánchez-Ibañez, Christine Humphreys, Mar Lomero, Manuel Escoto, Matthew J Weiss, Murray Wilson, Marta López-Fraga

Abstract read
In one paragraph

Article in Transplantation direct, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Meeting the Shortage of Human Cells and Tissues: The Andalusian Quality Assurance Programme for Tissue Donation.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jacinto Sánchez-IbañezA Coruña Tissue Bank, Cryobiology Unit, A Coruña University Hospital, Spain.
Christine HumphreysEye Bank of Canada (Ontario Division), Toronto, ON, Canada.
Mar LomeroDepartment of Biological Standardisation, OMCL Network & HealthCare (DBO), European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, Strasbourg, France.
Manuel EscotoCanadian Donation and Transplantation Research Program, Edmonton, AB, Canada.
Matthew J WeissCanadian Donation and Transplantation Research Program, Edmonton, AB, Canada.
Murray WilsonCanadian Donation and Transplantation Research Program, Edmonton, AB, Canada.
Marta López-FragaDepartment of Biological Standardisation, OMCL Network & HealthCare (DBO), European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, Strasbourg, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organ, tissue, and cell donation and transplantation legislation and policies vary substantially worldwide, as do performance outcomes in various jurisdictions. Our objective was to create expert, consensus guidance that links evidence and ethical concepts to legislative and policy reform for tissue and cell donation and transplantation systems. Methods: We identified topic areas and recommendations through consensus, using nominal group technique. The proposed framework was informed by narrative literature reviews and vetted by the project's scientific committee. The framework was presented publicly at a hybrid virtual and in-person meeting in October 2021 in Montréal, Canada, where feedback provided by the broader Forum participants was incorporated into the final manuscript. Results: This report has 13 recommendations regarding critical aspects affecting the donation and use of human tissues and cells that need to be addressed internationally to protect donors and recipients. They address measures to foster self-sufficiency, ensure the respect of robust ethical principles, guarantee the quality and safety of tissues and cells for human use, and encourage the development of safe and effective innovative therapeutic options in not-for-profit settings. Conclusions: The implementation of these recommendations, in total or in part, by legislators and governments would benefit tissue transplantation programs by ensuring access to safe, effective, and ethical tissue- and cell-based therapies for all patients in need.

Identifiers

PMID37138555
PMCPMC10150842

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.